Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of combining denosumab with ibandronate in postmenopausal osteoporosis patients sub-optimally treated with daily or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Denosumab (denosumab)
• Ibandronate (ibandronate)

Snippet

Sponsor: Amgen | Conditions: Postmenopausal Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2012-11-29